首页> 外文期刊>Molecules >LC-MS/MS Determination and Pharmacokinetic Study of Dehydrocorydaline in Rat Plasma after Oral Administration of Dehydrocorydaline and Corydalis yanhusuo Extract
【24h】

LC-MS/MS Determination and Pharmacokinetic Study of Dehydrocorydaline in Rat Plasma after Oral Administration of Dehydrocorydaline and Corydalis yanhusuo Extract

机译:口服口服去氢延胡索碱和延胡索提取物后大鼠血浆中LC-MS / MS的测定及药代动力学研究

获取原文
获取原文并翻译 | 示例
       

摘要

A rapid, sensitive and selective liquid chromatography/tandem mass spectrometry method (LC-MS/MS) was developed and validated for determination of dehydrocorydaline (DHC) in rat plasma using nitidine chloride as an internal standard. The analytes were solid-phase extracted and eluted on a C18 chromatography column using a mobile phase of acetonitrile and water (containing 0.8% formic acid and 10 mM ammonium acetate) (28: 72, v/v). Detection was performed using positive ion electrospray ionization in multiple reaction monitoring modes. The assay was linear over the concentration range 0.625-250 ng/mL with a quantification limit of 0.625 ng/mL. The precision was <13.7%, the accuracy >93.1%, and extraction recovery ranged from 92.1% to 107%. The validated method was successfully applied to the pharmacokinetics and excretion study of DHC in rat plasma after oral administration of pure DHC and an effective fraction of Corydalis yanhusuo (EFY). The pharmacokinetic parameters showed that DHC from EFY was absorbed more rapidly and eliminated more slowly than pure DHC. The result suggests that the differences might be due to the presence of P-glycoprotein (P-gp) inhibitors and that other alkaloids co-existing in the EFY may compete with DHC for transportation by P-gp, metabolization by P450, and binding to plasma proteins.
机译:建立了一种快速,灵敏且选择性的液相色谱/串联质谱方法(LC-MS / MS),并已验证该方法可用于以氯化亚硝胺为内标测定大鼠血浆中的脱氢钴红素(DHC)。固相萃取分析物,并使用乙腈和水(含0.8%甲酸和10 mM乙酸铵)的流动相,在C18色谱柱上洗脱(28:72,v / v)。使用正离子电喷雾电离以多种反应监测模式进行检测。该测定在浓度范围0.625-250 ng / mL范围内呈线性,定量限为0.625 ng / mL。精度<13.7%,精度> 93.1%,提取回收率在92.1%至107%之间。经验证的方法已成功应用于口服纯DHC和有效成分延胡索(EFY)的DHC在大鼠血浆中的药代动力学和排泄研究。药代动力学参数表明,与纯DHC相比,EFY中的DHC吸收更快,清除速度更慢。结果表明,差异可能是由于P-糖蛋白(P-gp)抑制剂的存在,并且EFY中共存的其他生物碱可能与DHC竞争通过P-gp转运,通过P450代谢以及与DHC结合血浆蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号